Evommune Inc (EVMN) Institutional Investor Snapshot (109 Funds, Q2 2026)

EVMN ranks #4392 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

EVMN is a top-conviction position for Nan Fung Group Holdings Ltd — at 14.6% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in EVMN belongs to EQT Fund Management S.a r.l., but the position matters far more to Nan Fung Group Holdings Ltd, who has 14.6% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Steve Cohen has added to its EVMN position for two straight quarters, increasing it by $18.5M to reach $19.1M today.

Sphera Funds Management LTD. has trimmed its EVMN position for two straight quarters, cutting it by $2.5M while still holding $300.8K.

EVMN is down 1.4% today, but institutions show net buying of $105.9M this quarter — a divergence between today's price move and the underlying institutional flow.

EVMN reported a net loss of $94.7M over the trailing twelve months.

• Not yet profitable — net loss of $94.7M over the trailing twelve months
• Net income declined year over year, from -$64.8M to -$94.7M
• Operating cash flow was negative, using $76.4M in cash
• Current ratio of 8.57x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.09x equity — within a conventional range